Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
出版年份 2023 全文链接
标题
Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
作者
关键词
-
出版物
NEUROLOGICAL SCIENCES
Volume 44, Issue 7, Pages 2455-2463
出版商
Springer Science and Business Media LLC
发表日期
2023-02-24
DOI
10.1007/s10072-023-06683-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- CGRP and PACAP-38 play an important role in diagnosing pediatric migraine
- (2022) Junhui Liu et al. JOURNAL OF HEADACHE AND PAIN
- Maintenance of response and predictive factors of 1‐year GalcanezumAb treatment in real‐life migraine patients in Italy : The multicenter prospective cohort GARLIT study
- (2022) Fabrizio Vernieri et al. EUROPEAN JOURNAL OF NEUROLOGY
- Association between response to triptans and response to erenumab: real-life data
- (2021) Ilaria Frattale et al. JOURNAL OF HEADACHE AND PAIN
- Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
- (2021) Fabrizio Vernieri et al. JOURNAL OF HEADACHE AND PAIN
- The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
- (2021) Marta Torres-Ferrús et al. JOURNAL OF NEUROLOGY
- Refractory migraine profile in CGRP‐monoclonal antibodies scenario
- (2021) Marcello Silvestro et al. ACTA NEUROLOGICA SCANDINAVICA
- Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project
- (2021) Piero Barbanti et al. HEADACHE
- MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
- (2021) Robert Belvís et al. JOURNAL OF HEADACHE AND PAIN
- Predictors of response to erenumab after 12 months of treatment
- (2021) Carlo Baraldi et al. Brain and Behavior
- Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months
- (2021) Edoardo Caronna et al. JOURNAL OF HEADACHE AND PAIN
- Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study
- (2021) Sara Bottiroli et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab for Migraine Prevention in a 1-Year Compassionate Use Program: Efficacy, Tolerability, and Differences Between Clinical Phenotypes
- (2021) Jean Schoenen et al. Frontiers in Neurology
- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Comparison of 3 Treatment Strategies for Medication Overuse Headache
- (2020) Louise Ninett Carlsen et al. JAMA Neurology
- Effect of Fremanezumab on Quality of Life and Productivity in Patients With Chronic Migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Placebo‐Controlled REGAIN, and Pooled EVOLVE‐1 and EVOLVE‐2 Studies
- (2020) Todd A. Smitherman et al. HEADACHE
- The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
- (2020) Stephen D. Silberstein et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
- (2020) Wim M Mulleners et al. LANCET NEUROLOGY
- Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2
- (2020) Hans‐Christoph Diener et al. HEADACHE
- Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study
- (2020) Piero Barbanti et al. HEADACHE
- Erenumab in chronic migraine with medication overuse
- (2019) Stewart J. Tepper et al. NEUROLOGY
- Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
- (2019) David W Dodick et al. CEPHALALGIA
- Migraine
- (2019) Rebecca C. Burch et al. NEUROLOGIC CLINICS
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Lars Jacob Stovner et al. LANCET NEUROLOGY
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Phenotypic features of chronic migraine
- (2016) Osman Özgür Yalın et al. JOURNAL OF HEADACHE AND PAIN
- Validation of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with migraine
- (2015) Jong-Geun Seo et al. JOURNAL OF HEADACHE AND PAIN
- Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine
- (2015) Jong-Geun Seo et al. JOURNAL OF HEADACHE AND PAIN
- Chronic Daily Headache in Korea: Prevalence, Clinical Characteristics, Medical Consultation and Management
- (2014) Jeong-Wook Park et al. Journal of Clinical Neurology
- CGRP and migraine: Could PACAP play a role too?
- (2013) Eric A. Kaiser et al. NEUROPEPTIDES
- Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain
- (2013) Rodrigo Noseda et al. PAIN
- Detoxification for medication overuse headache is the primary task
- (2011) Jes Olesen CEPHALALGIA
- Migraine Chronification
- (2011) Marcelo E. Bigal et al. Current Neurology and Neuroscience Reports
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Chronic Migraine: Epidemiology and Disease Burden
- (2010) Aubrey N. Manack et al. Current Pain and Headache Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search